<result><Target><Item><Target_ID> 2001</Target_ID>
<Target_Name>Platelet-rich plasma</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2002</Target_ID>
<Target_Name>CD177 antigen</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q8N6Q3</Target_Sequence>
<Synonyms>Human neutrophil alloantigen 2a, HNA-2a
NB1 glycoprotein, NB1 GP
Polycythemia rubra vera protein 1, PRV-1
CD_antigen: CD177</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2003</Target_ID>
<Target_Name>Purified serum IgG from a year 1 patient with advancing prostate cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</Comments>
</Item><Item><Target_ID> 2004</Target_ID>
<Target_Name>Purified serum IgG from a year 5 patient with advancing prostate cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</Comments>
</Item><Item><Target_ID> 2005</Target_ID>
<Target_Name>Purified serum IgG from a year 7 patient with advancing prostate cancer</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</Comments>
</Item><Item><Target_ID> 2006</Target_ID>
<Target_Name>Fibroblast growth factor receptor 3, FGFR-3</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P22607</Target_Sequence>
<Synonyms>CD_antigen: CD333</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1RY7,2LZL,4K33</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2007</Target_ID>
<Target_Name>Human sural nerve tissue</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2008</Target_ID>
<Target_Name>N-elastase</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2009</Target_ID>
<Target_Name>Myeloblastin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P24158</Target_Sequence>
<Synonyms>AGP7
C-ANCA antigen
Leukocyte proteinase 3
PR-3
PR3
Neutrophil proteinase 4, NP-4
P29
Wegener autoantigen</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1FUJ</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2010</Target_ID>
<Target_Name>Lysozyme</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Lysozyme (L 1096), was purchased from Sigma (St. Louis, MO, USA).</Comments>
</Item><Item><Target_ID> 2011</Target_ID>
<Target_Name>Isulin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P01308</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1A7F, 1AI0, 1AIY, 1B9E, 1BEN, 1EFE, 1EV3, 1EV6, 1EVR, 1FU2, 1FUB, 1G7A, 1G7B, 1GUJ, 1HIQ, 1HIS, 1HIT, 1HLS, 1HTV, 1HUI, 1IOG, 1IOH, 1J73, 1JCA, 1JCO, 1JK8, 1K3M, 1KMF, 1LKQ, 1LPH, 1MHI, 1MHJ, 1MSO, 1OS3, 1OS4, 1Q4V, 1QIY, 1QIZ, 1QJ0, 1RWE, 1SF1, 1SJT, 1SJU, 1T0C, 1T1K, 1T1P, 1T1Q, 1TRZ, 1TYL, 1TYM, 1UZ9, 1VKT, 1W8P, 1XDA, 1XGL, 1XW7, 1ZEG, 1ZEH, 1ZNJ, 2AIY, 2C8Q, 2C8R, 2CEU, 2G54, 2G56, 2H67, 2HH4, 2HHO, 2HIU, 2JMN, 2JUM, 2JUU, 2JUV, 2JV1, 2JZQ, 2K91, 2K9R, 2KJJ, 2KJU, 2KQP, 2KQQ, 2KXK, 2L1Y, 2L1Z, 2LGB, 2LWZ, 2M1D, 2M1E, 2M2M, 2M2N, 2M2O, 2M2P, 2MLI, 2MPG, 2MPI, 2MVC, 2MVD, 2N2V, 2N2W, 2N2X, 2OLY, 2OLZ, 2OM0, 2OM1, 2OMG, 2OMH, 2OMI, 2OMQ, 2QIU, 2R34, 2R35, 2R36, 2RN5, 2VJZ, 2VK0, 2W44, 2WBY, 2WC0, 2WRU, 2WRV, 2WRW, 2WRX, 2WS0, 2WS1, 2WS4, 2WS6, 2WS7, 3AIY, 3BXQ, 3E7Y, 3E7Z, 3EXX, 3FQ9, 3HYD, 3I3Z, 3I40, 3ILG, 3INC, 3IR0, 3JSD, 3KQ6, 3P2X, 3P33, 3Q6E, 3ROV, 3TT8, 3U4N, 3UTQ, 3UTS, 3UTT, 3V19, 3V1G, 3W11, 3W12, 3W13, 3W7Y, 3W7Z, 3W80, 3ZI3, 3ZQR, 3ZS2, 3ZU1, 4AIY, 4AJX, 4AJZ, 4AK0, 4AKJ, 4CXL, 4CXN, 4CY7, 4EFX, 4EWW, 4EWX, 4EWZ, 4EX0, 4EX1, 4EXX, 4EY1, 4EY9, 4EYD, 4EYN, 4EYP, 4F0N, 4F0O, 4F1A, 4F1B, 4F1C, 4F1D, 4F1F, 4F1G, 4F4T, 4F4V, 4F51, 4F8F, 4FG3, 4FKA, 4GBC, 4GBI, 4GBK, 4GBL, 4GBN, 4IUZ, 4IYD, 4IYF, 4NIB, 4OGA, 4P65, 4RXW, 4UNE, 4UNG, 4UNH, 4WDI, 4XC4, 4Y19, 4Y1A, 4Z76, 4Z77, 4Z78, 5AIY, 5BOQ, 5BPO, 5BQQ, 5BTS, 5C0D, 5CJO, 5CNY, 5CO2, 5CO6, 5CO9, 5E7W, 5EMS, 5EN9, 5ENA, 5HPR, 5HPU, 5HQI, 5HRQ, 5HYJ, 5MAM, 5MHD, 5MT3, 5MT9, 5MWQ, 5T7R, 5UDP, 5UOZ, 5UQA, 5URT, 5URU, 5USP, 5USS, 5USV, 5UU2, 5UU3, 5UU4, 5VIZ, 5WBT, 5WDM, 5WOB, 6B3Q, 6B70, 6BFC, 6CE7, 6CE9, 6CEB, 6CK2</Target_Structure>
<Comments>Human insulin (99.9%) was a generous gift of Gan &amp; Lee Biotechnology Ltd. (Beijing, China).</Comments>
</Item><Item><Target_ID> 2012</Target_ID>
<Target_Name>Bovine lactoferrin</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2013</Target_ID>
<Target_Name>Barley α-amylase 1</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>Crude enzyme from barley malt was precipitated, and the isozymes were separated by ion-exchange chromatography.</Comments>
</Item><Item><Target_ID> 2014</Target_ID>
<Target_Name>Anti-goat immunoglobulin G monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti-goat immunoglobulin G (IgG) antibody was purchased from Sigma (St. Louis, MO, USA).</Comments>
</Item><Item><Target_ID> 2015</Target_ID>
<Target_Name>Lipase (EC:3.1.1.3)</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>P19515</Target_Sequence>
<Synonyms>Triacylglycerol lipase</Synonyms>
<Target_Source>Rhizomucor miehei:4839</Target_Source>
<Target_Structure>1TGL, 3TGL, 4TGL, 5TGL</Target_Structure>
<Comments>Rhizomucor miehei lipase was purified to homogeneity from a crude preparation (Lipozyme 10,000 L; Novo Nordisk, Denmark)</Comments>
</Item><Item><Target_ID> 2016</Target_ID>
<Target_Name>Cystic fibrosis (CF) mucus</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Sus scrofa (Pig):9823</Target_Source>
<Target_Structure></Target_Structure>
<Comments>A cystic fibrosis mucus model (CF mucus) was adapted from McGill and Smyth (McGill and Smyth, 2010). The model comprises of 80 mg/mL mucin from porcine stomach type III (Sigma Aldrich, St. Louis, MO), 60 mg/mL mucin from porcine stomach type II (Sigma Aldrich, St. Louis, MO), 3.2 mg/mL lecithin (Spectrum Chemical, Gardena, CA), 32 mg/mL BSA (Fisher Scientific, Waltham, MA), 4.5 mg/mL NaCl (Fisher Scientific, Waltham, MA) in a 20mM HEPES buffer (Life Technologies, Waltham, MA). The reagents were transferred to a sterile tube and mixed overnight at room temperature in a shaker at 5 rpm (Thermo Fisher Scientific, Waltham, MA).</Comments>
</Item><Item><Target_ID> 2017</Target_ID>
<Target_Name>Trypsin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2018</Target_ID>
<Target_Name>Chymotrypsin</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Bos taurus (Bovine):9913</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2019</Target_ID>
<Target_Name>Terbium doped cerium-magnesium aluminate (CAT)</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>Terbium doped cerium-magnesium aluminate (CAT) (Leuchtstoffe Breitungen GmbH, Germany), an indispensable part of fluorescent powder of compact light bulbs, was used for the selection of specific binding peptides out of recombinant phage library.</Comments>
</Item><Item><Target_ID> 2020</Target_ID>
<Target_Name>Serum 13006 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2065</Target_ID>
<Target_Name>Serum 14008 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2066</Target_ID>
<Target_Name>Serum 13009 from patients sensitized to soy bean</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2021</Target_ID>
<Target_Name>Nickel ion</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments>The biopanning selection process of phage for ion specific binding has been accomplished using planar sol gel materials (GMBU e.V., Germany) with ion exchange properties. Sol gel materials were prepared with cationic binding capacity using tetraethylorthosilicate (TEOS) and different polymers (15% w/w Dispex N40, polyacrylic acid or polystyrene sulfonate). For biopanning the sol gel materials were loaded with divalent nickel-salt containing buffers.</Comments>
</Item><Item><Target_ID> 2022</Target_ID>
<Target_Name>Virus-like particle (VLP) of orange-spotted grouper nervous necrosis virus (OGNNV)</Target_Name>
<Target_Type></Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2023</Target_ID>
<Target_Name>C57BL/6 mouse bone marrow mesenchymal stem cell (BMMSC)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments>C57BL/6 mouse BMMSCs (cat. no. MUBMX-01001) were obtained from Cyagen Biosciences, Inc., (Santa Clara,  CA, USA).  Mouse BMMSCs at passage 4-5 were used for biopanning.</Comments>
</Item></Target></result>